1. Home
  2. Analysis

Agranulocytosis and drugs of ingredients of granisetron (a real world drug study)


Summary:

Agranulocytosis is found among people who take drugs with ingredients of granisetron, especially for people who are female, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 1,770 people who have side effects when taking drugs with ingredients of granisetron from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Sancuso, Sustol.

On Jul, 04, 2026

1,770 people reported to have side effects when taking drugs with ingredients of granisetron.
Among them, 43 people (2.43%) have Agranulocytosis

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,327 drugs and 3,591 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

Number of reports submitted per year:

Could drugs with ingredients of granisetron cause Agranulocytosis?

Time on drugs with ingredients of granisetron when people have Agranulocytosis *:

  • < 1 month: 87.5 %
  • 1 - 6 months: 12.5 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Agranulocytosis when taking drugs with ingredients of granisetron *:

  • female: 69.77 %
  • male: 30.23 %

Age of people who have Agranulocytosis when taking drugs with ingredients of granisetron *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 10 %
  • 30-39: 5 %
  • 40-49: 30 %
  • 50-59: 20 %
  • 60+: 35 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Febrile Neutropenia (fever with reduced white blood cells): 9 people, 20.93%
  2. Breast Cancer: 9 people, 20.93%
  3. Lung Cancer - Small Cell (lung cancer): 8 people, 18.60%
  4. Insomnia (sleeplessness): 4 people, 9.30%
  5. Nausea (feeling of having an urge to vomit): 4 people, 9.30%
  6. Neuropathy Peripheral (surface nerve damage): 4 people, 9.30%
  7. Cancer Pain: 3 people, 6.98%
  8. Constipation: 3 people, 6.98%
  9. Diabetes: 3 people, 6.98%
  10. High Blood Pressure: 3 people, 6.98%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Lasix: 13 people, 30.23%
  2. Aloxi: 5 people, 11.63%
  3. Kytril: 4 people, 9.30%
  4. Megace: 4 people, 9.30%
  5. Emend: 3 people, 6.98%
  6. Xgeva: 3 people, 6.98%
  7. Pantoprazole: 2 people, 4.65%
  8. Baraclude: 2 people, 4.65%
  9. Celebrex: 2 people, 4.65%
  10. Gemzar: 2 people, 4.65%

Other side effects people have besides Agranulocytosis *:

You may use this to check any potential undetected side effects.

  1. Nausea (feeling of having an urge to vomit): 15 people, 34.88%
  2. Nausea And Vomiting: 7 people, 16.28%
  3. Diarrhea: 7 people, 16.28%
  4. Anaemia (lack of blood): 6 people, 13.95%
  5. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 11.63%
  6. Dyspnea (difficult or laboured breathing): 5 people, 11.63%
  7. Cough: 5 people, 11.63%
  8. Gastroenteritis (inflammation of stomach and intestine): 4 people, 9.30%
  9. Indigestion: 4 people, 9.30%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of granisetron, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on granisetron. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.